Perspective Therapeutics Inc (CATX)
SG&A Expense Growth
11.60%
Quarterly · Period ending:
CATX SG&A Expense Growth
Latest reported11.60%period ending
Latest reported11.60%period ending
CATX Quarterly SG&A Growth (QoQ) (0.00% → 11.60%)
Latest values, visible window
High-resolution chart · PNG
CATX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 11.5963% | |
| 0.4891% | |
| -10.0893% | |
| 0.2854% | |
| 10.5233% | |
| -15.4135% | |
| 18.2222% | |
| 26.3129% | |
| 23.7007% | |
| 163.5183% | |
| -71.6912% | |
| 19.992% | |
| -36.3497% | |
| 161.7775% | |
| -23.5309% | |
| 75.0447% | |
| -1.4109% | |
| -2.2414% | |
| -10.8035% | |
| 31.9635% | |
| 11.7347% | |
| 0.9153% | |
| 6.068% | |
| -14.9639% | |
| -1.1224% | |
| 12.8382% | |
| -9.1527% | |
| 13.6742% | |
| -3.555% | |
| -3.2723% | |
| 11.1591% | |
| -27.4273% | |
| 51.5254% | |
| -11.091% | |
| 14.0206% | |
| -28.8509% | |
| 50.9225% | |
| -1.5262% | |
| -5.1688% | |
| -4.5373% | |
| 25.6026% | |
| -12.255% | |
| 33.8812% | |
| -10.6239% | |
| 19.4621% | |
| 14.6232% | |
| -9.4624% | |
| -7.4822% | |
| 18.58% | |
| -0.9449% | |
| -15.3143% | |
| 2.7825% | |
| 14.9711% | |
| 7.9876% | |
| -17.6142% | |
| -0.6329% | |
| 15.8338% | |
| 4.1875% | |
| -17.1663% | |
| 4.4767% | |
| 7.3131% | |
| -3.7936% | |
| -7.5022% | |
| -15.7274% | |
| 10.2101% | |
| -9.5384% | |
| 10.3947% | |
| -2.5011% | |
| -10.3547% | |
| -13.3043% | |
| -8.6972% | |
| -0.0374% | |
| -14.0161% | |
| -14.7483% | |
| 5.1049% | |
| -18.0796% | |
| 33.9644% | |
| 4.4464% | |
| -28.8652% | |
| 53.4766% | |
| 47.2921% | |
| 4.7615% | |
| -20.3773% | |
| 0% | |
| -31.1696% | |
| -14.272% | |
| -44.205% | |
| 369.0521% | |
| -45.7055% | |
| -57.9113% | |
| 292.9538% | |
| -34.4904% | |
| -64.2272% | |
| 2,893.3579% | |
| -118.2984% | |
| -69.6454% | |
| 226.3545% | |
| -69.3585% | |
| -55.0323% | |
| 1,012.8205% |